Latest Market Pricing News

Racura Oncology reported a transformative quarter with key scientific discoveries, expanded clinical programs, and a robust cash position of $20.94 million, setting the stage for pivotal cancer trials in 2026.

AuKing Mining Ltd has agreed to acquire 100% of tin and silver exploration licences adjacent to Tasmania’s Renison Bell mine, tapping into a historically rich mining district amid surging tin prices.

Osmond Resources has reported exceptional initial drilling results from its Orión EU Critical Minerals Project in Spain, advancing towards a maiden Mineral Resource Estimate and Scoping Study in 2026. A recent $6.6 million placement boosts the company’s cash position to over $8.5 million, underpinning further development.

BMC Minerals Ltd. reported a strong cash position of $64.9 million following its December 2025 ASX listing, supported by significant financing inflows and a secured agreement with Wheaton Precious Metals Corp.

Metro Mining delivered a record 6.2 million wet metric tonnes in 2025 shipments, supported by a strong cash position and nearing completion of legacy contracts. The company is poised for expanded production and improved margins in 2026 following operational and leadership changes.

Stockland announces a 9-cent unfranked dividend for the half-year ending December 2025, alongside a Dividend Reinvestment Plan priced at $5.47 per security. The DRP offers investors a 1% discount and new securities issued will rank equally from the issue date.

Metals Australia Ltd is progressing pre-feasibility studies for its Lac Carheil Graphite Project in Quebec, aligning with the province’s new strategy to accelerate critical minerals development. The project’s expanded resource and downstream battery material plans position it well for North American markets.

GWR Group Limited reports a robust cash position of $75 million and progresses its Prospect Ridge Magnesite Project alongside strategic investments in tungsten and royalties from iron ore and gold assets.

Lithium Universe’s Bécancour Lithium Refinery project in Québec is poised to capitalise on a sharp lithium price rebound, with current prices well above feasibility study forecasts. The company’s counter-cyclical development strategy is gaining momentum amid renewed market confidence.

Highfield Resources has secured a A$10 million investment from existing strategic shareholders, extending its financial runway through early 2027 while awaiting a critical Spanish Supreme Court ruling on its Goyo mining permit appeal.

Assetora Limited has announced a $4 million pro-rata rights issue priced at $0.16 per share, with half the offer underwritten by existing shareholders to strengthen its balance sheet and repay debt.

Cambium Bio has strengthened its financial footing with a $0.6 million R&D tax refund and a $2.4 million strategic placement, setting the stage for pivotal Phase 3 clinical trials of its lead ophthalmology candidate.